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Improved Outcomes After Aortic Valve
Surgery for Chronic Aortic Regurgitation
With Severe Left Ventricular Dysfunction
Sunil K. Bhudia, MD,* Patrick M. McCarthy, MD,* Ganesh S. Kumpati, MD,* Joe Helou, MD,*
Katherine J. Hoercher, RN,* Jeevanantham Rajeswaran, MSC,† Eugene H. Blackstone, MD*†
Cleveland, Ohio
Objectives Among patients undergoing aortic valve surgery for chronic aortic regurgitation (AR), we sought to: 1) compare
survival among those with and without severe left ventricular dysfunction (LVD); 2) identify risk factors for death,
including LVD and date of operation; and 3) estimate contemporary risk for cardiomyopathic patients.
Background Patients with chronic AR and severe LVD have been considered high risk for aortic valve surgery, with limited
prognosis. Transplantation is considered for some.
Methods From 1972 to 1999, 724 patients underwent surgery for chronic AR; 88 (12%) had severe LVD. They were pro-
pensity matched to patients with nonsevere LVD to compare hospital mortality, interaction of operative date
with severity of LVD, and late survival. Propensity score-adjusted multivariable analysis was performed for all
724 patients to identify risk factors for death.
Results Survival was lower (p  0.04) among patients with severe LVD than among matched patients with nonsevere
LVD (30-day, 1-, 5-, and 25-year survival estimates were 91% vs. 96%, 81% vs. 92%, 68% vs. 81%, and 5% vs.
12%, respectively). However, survival of patients with severe LVD improved dramatically across the study time
frame (p  0.0004): hospital mortality decreased from 50% in 1975 to 0% after 1985, and time-related survival
in patients with severe LVD operated on since 1985 became equivalent to that of matched patients with nonse-
vere LVD (p  0.96).
Conclusions Neutralizing risk of severe LVD has improved early and late survival such that aortic valve surgery for chronic AR
and cardiomyopathy is no longer a high-risk procedure for which transplantation is the best option. (J Am Coll
Cardiol 2007;49:1465–71) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.01.026c
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wuidelines for managing aortic regurgitation (AR) in pa-
ients with normal left ventricular (LV) function generally
re clear (1,2). However, for patients with AR-induced
ardiomyopathy, manifested at times by massive ventricular
ilation from volume overload, management guidelines
eflect conflicting evidence, and operative results have been
ifficult to predict (1). Heart transplantation has sometimes
een suggested (3).
See page 1472
Previous studies have identified greater severity of LV
ysfunction (LVD) as a risk factor for poor long-term
utcome among patients treated both surgically and medi-
rom the Departments of *Thoracic and Cardiovascular Surgery and †Quantitative
ealth Sciences, Cleveland Clinic, Cleveland, Ohio.C
Manuscript received May 26, 2006; revised manuscript received October 25, 2006,
ccepted November 1, 2006.ally (4–6). However, recent reports of mitral valve surgery
n patients with both severe regurgitation and severe LVD
also historically considered a high-risk procedure) have
emonstrated good early and late survival, relief of symp-
oms, and improved LV geometry (7,8). In light of these
esults, we reexamined valve surgery for AR in patients with
evere LVD. Specifically, among patients undergoing aortic
alve surgery for chronic AR, we sought to: 1) compare
urvival among those with versus without severe LVD; 2)
dentify risk factors for death, including LVD and operative
ate; and 3) estimate the contemporary risk of aortic valve
urgery for the cardiomyopathic patient.
atients and Methods
atients. From January 1972 to January 1999, 724 patients
nderwent primary isolated aortic valve surgery (replace-
ent, n  722; repair, n  2) for chronic AR, with or
ithout concomitant repair of the aorta, at Cleveland
linic. Preoperative, operative, and postoperative variables
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graphic variables were retrieved
from the prospective Cardiovas-
cular Information Registry and
Echocardiography Database, re-
spectively. Both were approved
for use in research by the institu-
tional review board.
Inclusion criteria. The study
population comprises patients
ith moderately severe or severe AR of at least 3 months’
uration, including ones with chronic aortic dissection (all
ad diagnosis of dissection 3 months or more before
urgery), coexisting ascending aortic aneurysm, or connec-
ive tissue diseases (Marfan syndrome and cystic medial
ecrosis).
xclusion criteria. Patients not having primary, isolated
ortic valve surgery or aortic valve surgery with concomitant
epair of the aorta were excluded. Also excluded were
atients who had mixed aortic stenosis and regurgitation
because the fundamental pathophysiology of valves with
tenosis is different than for pure regurgitation), previous
hest radiation, unknown duration of aortic dissection, or
ndocarditis within 3 months of operation (defined as
lood-culture positive or systemic sepsis with the clinical
yndrome of infective endocarditis, culture-positive valvar
egetations, or antibiotic treatment for diagnosed or sus-
ected endocarditis).
VD groups. Of the 724 patients, 88 (12%) had a LV
jection fraction of 30% or less on preoperative left ven-
riculogram or echocardiogram; they constituted the severe
VD group. The remaining patients (n  636) had LV
jection fraction greater than 30% and were designated the
onsevere LVD group. A subgroup of patients from 1986
nward had preoperative echocardiographic measurements
f structure and function, and these revealed the expected
arger LV diastolic (7.5  0.7 cm vs. 6.4  1.0 cm, p 
.0001) and systolic (5.9  0.79 cm vs. 4.2  0.89 cm, p 
.0001) dimensions of the severe LVD group, reduced
ractional shortening (0.22  0.07 vs. 0.34  0.08, p 
.0001), but similar wall thickness (1.2  0.23 cm vs. 1.2 
.24 cm, p  0.5) (Appendix A).
Characteristics of these groups and their operation are
ontrasted in Table 1. In patients with severe LVD, mean
ge was 56  12 years, and 80 (91%) were men. The most
ommon etiologies of AR were degeneration (59%) and
nuloaortic ectasia without aneurysm (28%). In contrast,
atients with nonsevere LVD were younger (mean age 50
5 years), and a smaller proportion were men (67%), but the
ost common etiologies of AR were similar: degeneration
n 49% and anuloaortic ectasia in 30%. Both groups had
imilar prevalence of aorta repairs.
Before 1985, the proportions of mechanical (n  165 of
52 replacements, 47%) and biological (n  187, 53%)
rostheses implanted were nearly equal. Since 1985, biolog-
Abbreviations
and Acronyms
AR  aortic valve
regurgitation
CL  confidence limits
LV  left ventricular
LVD  left ventricular
dysfunctioncal prostheses have been implanted somewhat more fre- guently (n 211 of 370 replacements, 57%); however, 80 of
hese were allografts, which were not used before 1985.
nd points. Patients were followed routinely every 2 years
fter surgery and cross-sectionally in 2001 to determine
unctional status, vital status, and whether they had under-
one cardiac reoperation. For patients who were untraced,
he Social Security Death Index was used to estimate vital
tatus (9,10).
Follow-up extended reliably to 25 years, with 5,785
atient-years of information available for analysis. Among
urvivors, median follow-up was 6 years (mean 8.3  6.5
ears), with 75% followed for more than 3 years, 25% more
or 13 years, and 10% more than 19 years.
ata analysis. Data analysis addressed the following ques-
ions: 1) What is the difference in time-related survival after
ortic valve surgery between patients with versus without
evere LVD, but who are otherwise comparable? 2) What
re the risk factors for mortality? Specifically, after adjusting
or other risk factors, did LVD and date of surgery affect
arly versus long-term mortality differently? 3) What is the
mpact of LVD on mortality in the current era?
urvival comparison. Characteristics of patients with se-
ere LVD differed in many ways from those of patients with
onsevere disease (Table 1). Therefore, to make a fair
urvival comparison given the impossibility of randomizing
atients to having severe LVD or not, we used propensity
atching (11,12). In brief, multivariable logistic regression
nalysis was used to identify factors associated with severe
VD (Table 2, Appendix B), and to these were added
ariables representing groups of demographic, symptomatic,
nd comorbid factors that might be related to unrecorded
election factors (saturated model). The c statistic was 0.84.
propensity score was calculated for each patient by solving
he saturated model for the probability of being in the severe
VD group. Propensity-matched pairs were then selected
sing a greedy matching strategy. This yielded 77 well-
atched pairs of patients (Appendix C).
Nonparametric survival estimates were obtained using the
aplan-Meier method (13). A parametric method was used
o resolve the number of phases of instantaneous risk of
eath (hazard function) and to estimate shaping parameters
f each (14). Survival comparison was performed in the
azard function domain for propensity-matched patients.
isk factors for mortality. A multivariable analysis of all
24 patients was performed simultaneously for each hazard
hase, with an indicator for severe LVD forced into each
hase (Appendix B). Bootstrap bagging using 250 re-
ampled data sets was then used to identify other risk factors
ppearing in at least 50% of the models at p  0.05 (15).
ecause of the limited number of events, the propensity
core for each patient was then also forced into the model to
urther adjust for known differences between patients with
nd without severe LVD (16).
evere LVD in the current era. The influence of a risk
actor, such as severe LVD, on survival can be neutralized by
eneral improvements in surgical and medical care of
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e quantified the latter by examining the interaction of
evere LVD with date of surgery. Such an analysis permits
stimation of patient prognosis in the current era by solving
he resulting multivariable equation for the patient’s risk
actors, but substituting a contemporary date of operation.
To confirm and amplify understanding of the influence of
ate of operation, we also examined hospital mortality and
ong-term survival in propensity-matched pairs operated on
efore and after January 1, 1985 (35 patients with severe
VD and 37 with nonsevere LVD underwent surgery after
hat date).
resentation. Simple descriptive statistics were used to
ummarize the data. Categorical data are summarized as
Patient Characteristics and Procedure Details: C
Table 1 Patient Characteristics and Proced
Characteristic
Overall
(n  724), n
Demographics
Male 567 (78
Age, yrs
40 179 (25
40–50 137 (19
50–60 148 (20
60–70 164 (23
70 96 (13
NYHA functional class
I 204 (28
II 357 (49
III 130 (18
IV 31 (4)
Not documented 2 (0.3
Etiology of AR
Degenerative 363 (50
Anuloaortic ectasia without aneurysm 217 (30
Rheumatic 184 (25
Ascending aortic aneurysm 178 (25
Thoracic aneurysm 103 (14
Marfan syndrome 100 (14
Cusp perforation from previous
endocarditis
71 (10
Other 51 (7)
Comorbidities
Myocardial infarction 71 (10
Atrial fibrillation 38 (5)
Renal disease 6 (1)
COPD 20 (3)
Diabetes 12 (2)
PVD 39 (5)
Carotid disease 12 (2)
Aortic valve surgery
Alone 532 (73
Plus repair of aorta 192 (27
*Fisher exact test.
AR  aortic regurgitation; COPD  chronic obstructive pulmonary
disease.requencies and percentages, with comparisons made using Lhi-square and the Fisher exact tests. Continuous variables
re summarized as mean  standard deviation, with com-
arisons made using the Wilcoxon rank-sum nonparametric
est. Analyses were performed using SAS statistical software
version 9.1, SAS Institute, Cary, North Carolina). Uncer-
ainty is expressed by confidence limits (CLs) equivalent
o 1 standard error (68%).
esults
urvival comparison across entire study time frame. Sur-
ival after aortic valve surgery across the entire study time
rame was worse among propensity-matched patients with
evere LVD than otherwise-similar patients with nonsevere
orical Variables
etails: Categorical Variables
Left Ventricular Dysfunction
Severe
(n  88), n (%)
Nonsevere
(n  636), n (%) p Value
80 (91) 487 (67) 0.002
0.008
10 (11) 169 (27)
19 (22) 118 (19)
16 (18) 132 (21)
30 (34) 134 (21)
13 (15) 83 (13)
0.0001
13 (15) 191 (30)
39 (44) 318 (50)
29 (33) 101 (16)
7 (8) 24 (4)
0 (0) 2 (0.3)
52 (59) 311 (49) 0.07
25 (28) 192 (30) 0.7
20 (23) 164 (26) 0.5
17 (19) 161 (25) 0.2
10 (11) 93 (15) 0.4
14 (16) 86 (14) 0.5
5 (6) 66 (10) 0.2
7 (8) 44 (7) 0.7
11 (13) 60 (9) 0.4
9 (10) 29 (5) 0.03
3 (3) 3 (0.5) 0.03*
2 (2) 18 (3) 1.0*
3 (3) 9 (1) 0.1*
5 (6) 34 (5) 0.9
1 (1) 11 (2) 1.0*
71 (81) 461 (72) 0.1
17 (19) 172 (28) 0.1
e; NYHA  New York Heart Association; PVD  peripheral vascularateg
ure D
(%)
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t 20 years, and 5% vs. 12% at 25 years, respectively) (p [log
ank]  0.04) (Fig. 1A). Difference in survival was consider-
bly greater in unadjusted comparisons (Appendix Figure 1).
he hazard ratio comparing patients with severe LVD
ersus nonsevere LVD was greater than unity both early and
ate after surgery; although the ratio was 2 early after
urgery, its confidence limits suggest an increased propor-
ional hazard across years of follow-up (Fig. 1B).
isk factors for mortality. Among all 724 patients, severe
VD was a risk factor for early and late mortality and
emained so after adjusting for propensity score (Table 3).
arly date of surgery within the series was a risk factor for
arly mortality, and risk of death decreased for both severe
p 0.0004) and nonsevere (p 0.001) LVD patients over
he study time frame. The decline in risk was similar (p 
.3) for both groups.
evere LVD in the current era. HOSPITAL MORTALITY.
ospital mortality among propensity-matched patients un-
ergoing surgery before 1985 was 17% in the severe LVD
roup (7 of 42; CL 11% to 25%) and 3% in the nonsevere
VD group (1 of 40; CL 0.3% to 8%; p 0.03). From 1985
nward, hospital mortality was 0% for both groups (0 of 35
evere LVD patients, 0 of 37 nonsevere LVD patients, both
L 0% to 5%; p  1) (Fig. 2).
ONG-TERM SURVIVAL. In large part because of the oppor-
unity for more substantial decline of early risk in the severe
VD group, 10-year survival in propensity-matched pa-
ients who underwent surgery in 1973 was 20%, increased to
9% by 1985, and reached 60% by the mid-1980s. Thus, by
he mid-1980s, survival in this group became equivalent
widely overlapping confidence limits) to that of non-severe
actors Associated With Severe LV Dysfunction*
Table 2 Factors Associated With Severe LV Dysfunction*
Factor
Logistic
Coefficient  SE p Value
Reliability
(%)†
Demographic
Male 1.3 0.42 0.002 53
Older age‡ 1.2 0.48 0.009 62
Cardiovascular morbidity
Presence of mitral regurgitation 0.68 0.28 0.01 66
Ventricular arrhythmia 1.5 0.51 0.004 75
Higher NYHA functional class§ 0.14 0.031 0.0001 96
Lower LV systolic blood
pressure
0.019 0.0055 0.0003 99
Noncardiac comorbidity
Higher BUN¶ 1.3 0.35 0.0001 97
Higher triglycerides 1.1 0.29 0.0001 98
Intercept 9.1 2.1
Multivariable logistic regression analysis. †Percent of bootstrap models in which variable ap-
eared (see Patients and Methods). ‡(50/age), inverse transformation. §(NYHA functional class)2,
quared transformation. ¶Ln(BUN), logarithmic transformation. Ln(triglyceride), logarithmic trans-
ormation.
BUN  blood urea nitrogen; LV  left ventricular; NYHA  New York Heart Association; SE 
tandard error.VD patients (Fig. 3).ong-term survival in patients who underwent surgery in
985 and after. Among propensity-matched patients op-
rated on in 1985 and beyond, survival at 1, 5, and 10 years
fter surgery was 92%, 79%, and 51% for severe LVD
atients and 96%, 83%, and 55% for nonsevere LVD
atients, respectively (p  0.9) (Fig. 4).
iscussion
rincipal findings. Previous studies have shown that long-
erm results of aortic valve replacement are poor in patients
ith preoperative severe LVD (17,18). We also found that
ong-term survival across the entire study time frame was
orse in those with severe LVD.
However, because our study extended from 1972 to 1999,
e were also able to investigate the influence that date of
peration (with coincident improvements in medical and
urgical management and valvar prostheses) had on early
nd late survival. Long-term survival of patients with severe
Figure 1 Mortality After Aortic Valve Surgery in Propensity-
Matched Patients With and Without Severe LVD
(A) Survival. Each square (severe left ventricular dysfunction [LVD] group) and
circle (nonsevere LVD group) represents an event; vertical bars represent con-
fidence intervals equivalent to 1 standard error (68% confidence limit). Num-
bers in parentheses represent patients at risk for death. Solid lines are para-
metric estimates enclosed within 68% confidence limits. (B) Hazard ratio com-
paring hazard for death of patients with severe versus nonsevere LVD enclosed
within 68% confidence limits.
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April 3, 2007:1465–71 Surgery for Aortic Regurgitation and LV DysfunctionVD improved progressively and by about 1985 was com-
arable with that of patients with nonsevere LVD; hospital
ortality decreased to a comparable value. Early and late
urvival was already good and did not change appreciably
ver the experience in patients with better LV function.
Furthermore, severe LV dysfunction was associated with
xtremely enlarged ventricles and large volumes, with mean
V diastolic dimension of 7.5 cm and end-systolic dimen-
ion of 5.9 cm, as noted in Appendix A. Tables 1 and 2
resent other markers for high-risk patients. Clinicians
Figure 2 Hospital Mortality in Propensity-Matched
Patients Across the Clinical Experience
Solid lines are parametric trend lines enclosed within dashed 68% confidence
limits. Aggregated raw mortality is represented by symbols (squares for severe
LVD group and circles for the nonsevere group). Abbreviations as in Figure 1.
isk Factors for Mortality in the Entire Group
Table 3 Risk Factors for Mortality in the Entire Group
Factor Coefficient  SE p Value
Early hazard phase
Severe LV dysfunction 1.19 0.49 0.01
Earlier date of operation 0.101 0.021 0.0001
And LV dysfunction* 0.042 0.043 0.3
Older age† 0.62 0.16 0.0001
Thoracic aneurysm 0.59 0.27 0.03
Presence of mitral regurgitation 0.66 0.28 0.02
Propensity score 0.11 0.67 0.9
Late hazard phase
Severe LV dysfunction 2.5 0.88 0.004
Older age
In nonsevere LV dysfunction group‡ 0.85 0.12 0.0001
In severe LV dysfunction group§ 0.18 0.26 0.5
RCA disease (any) 0.65 0.22 0.004
Higher BUN¶ 0.17 0.036 0.0001
Propensity score 1.7 0.46 0.0003
Equivalently, this and the previous factor can be considered as separate subgroups, with earlier
ate of operation representing nonsevere patients (interaction) and earlier date in the severe
ysfunction group as 0.14  0.041, p  0.0004. †Exp(age/50). ‡Exp(age/50) in nonsevere LV
ysfunction group (interaction term). §Exp(age/50) in severe LV dysfunction group (interaction
erm). ¶(BUN/20)2, squared transformation.
RCA  right coronary artery; other abbreviations as in Table 2.hould be aware that patients with these characteristics can
ecover after surgery.
mplications for therapy. Guidelines for managing pa-
ients with AR and normal LV function generally are clear,
ut for patients with severe LVD, they reflect conflicting
vidence because the results of surgery have historically been
oor (19). It is recommended that patients with AR and in
ew York Heart Association functional class III or IV with
reserved LV function, those in functional class II with
rogressive LV dilation or angina, and asymptomatic pa-
Figure 3 Ten-Year Predicted Survival in Propensity-
Matched Patients According to Date of Operation
Data derived from a multivariable model containing group (severe vs. nonse-
vere LVD), date of operation, and interaction of group with date of operation.
Solid lines represent parametric estimates enclosed within 68% confidence
limits. Abbreviations as in Figure 1.
Figure 4 Survival in Propensity-Matched
Patients Undergoing Surgery in 1985 and Beyond
Depiction is as in Figure 1A. Solid lines represent predicted survival obtained
for each matched patient by solving the overall, multivariable risk-adjusted
equation in Table 3. They are enclosed within 68% confidence limits. Abbrevia-
tions as in Figure 1.
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Surgery for Aortic Regurgitation and LV Dysfunction April 3, 2007:1465–71ients with mild-to-moderate LVD should undergo aortic
alve surgery. Surgery also should be performed in patients
ith moderate-to-severe AR undergoing a concomitant
ardiac surgery. However, patients with severe LVD and
ymptomatic patients with advanced LVD have presented
ifficult management issues (19).
Unfortunately, patients with AR may not present until
hey have advanced heart failure with severe LVD and
entricular dilation. The natural history of such patients
and even of patients with AR and preserved LV function)
s limited (20). For some, heart transplantation has been
onsidered because of perceived high perioperative mortality
nd poor late survival after aortic valve surgery (3). How-
ver, we have shown in this study that aortic valve surgery in
atients with chronic AR and cardiomyopathy is no longer
high-risk procedure for which transplantation is a better
ption. Neutralization of the effect of severe LVD was
ccomplished by improved early results of aortic valve
urgery in general, not by specific improvements for these
atients alone.
There are many reasons that patients fare better after
urgery in the current era. Medical management of LV
ysfunction and heart failure improved substantially since
he earliest time frame of this study, with use of
ngiotensin-converting enzyme inhibitors and beta blockers
ecoming routine. Intraoperatively, myocardial protection
ecame more sophisticated for patients with LV dysfunc-
ion, with antegrade and retrograde cold-blood cardioplegia
ecoming routine. Intraoperative transesophageal echocar-
iography now allows the surgeon to reduce complications,
uch as atheroembolism from aortic calcification, and aids in
ptimizing inotrope management of LV function and re-
oval of intraventricular air. Compared with the Starr-
dwards high-gradient prosthesis used in the early days,
eplacement heart valves are considerably improved, with
ow-gradient bioprostheses and mechanical valves readily
vailable. Perioperative management now includes use of
ewer inotropes such as the phosphodiesterase inhibitor
ilrinone. Finally, postoperative optimal medical therapy
nd device options, such as biventricular synchronous pacing
nd implantable cardioverter-defibrillators, are now avail-
ble to improve mid-term survival.
tudy limitations. This was a clinical study with data
ollected from our prospective clinical registries. It thus
eflects the inherent bias of such studies, including referral
iases and patient selection bias. Because LV dysfunction is
ot randomizable, we used propensity adjustment in mul-
ivariable modeling and matching to reduce uncontrollable
atural selection bias. Nonsignificance of the propensity
core in early hazard indicates that usual clinical variables
ufficed for this, but not for late hazard, where it provided
mportant bias reduction over and above that provided by
ndividual clinical variables.
Duration of preoperative AR could not be determined
nd conceivably differed between groups; perhaps the severe rVD group had more long-standing AR. This was also a
ingle-institution study whose results may not be general-
zable. Unfortunately, we have been unable to identify
hich of many factors contributed to lowering of mortality,
ut we believe they include those discussed above.
Yet, it is conceivable that the progressive decline in early
ortality, particularly from the 1970s through the mid-
980s, could be an artifact of temporal changes in data
uality, definitions, or methods of assessment of LV func-
ion (echocardiogram vs. ventriculogram). We believe this is
ot the case. First, although there is imperfect correlation of
chocardiography and ventriculography, most of the decline
n mortality occurred in the era of routine ventriculography.
econd, there has been an ongoing, active quality assurance
nd improvement process for the primary registry used in
his study. Although specific temporal changes in the
atabase, generally corresponding to discrete changes in
merican College of Cardiology/Society of Thoracic Sur-
eons definitions, have occurred, we have not observed
emporal drifts.
In addition, the most dramatic decline in mortality has
een that which occurrs in-hospital. Although hospital
ortality is a hard, completely documented end point, it
oes not encompass the entire period of early surgical risk.
his phenomenon has been long recognized by surgeons, as
etailed in all 3 editions of Cardiac Surgery (21). It stimu-
ated Blackstone and colleagues to develop their temporal
ecomposition methods for time-related analysis in the
arly 1980s, which is a nonproportional hazards model that
an identify risk factors that dominate early after surgery,
nd possibly different ones that modulate late risk (15,22).
he use of this model leads to a more medically meaningful
nalysis of postintervention events than does a proportional-
azards model. Thus, hospital mortality, which is surely
nfluenced by ever-shorter length of hospital stay and
nderestimates early risk even more in serious conditions
han in straightforward cardiac surgery, is surely not an ideal
nd point (23). For this reason, the primary analysis for this
tudy has used all deaths from surgery through end of
ollow-up and the temporal decomposition method to
dentify associations of severe LVD and date of operation
ith mortality in each phase of hazard.
onclusions
lthough severe LVD has been a risk factor for reduced
arly and late survival after aortic valve surgery for AR, it has
een neutralized in this series since 1985. Patients should
till be referred for surgery earlier in their clinical course, or
er American Heart Association/American College of Car-
iology guidelines (19). However, for the patient who
resents late with AR and severe LVD, surgery is the
referred treatment and can be performed with acceptable
isk and late survival.
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